Yingxia Zheng
- Immunology top 5%
- Immune Cell Function and Interaction 9
- T-cell and B-cell Immunology 7
- IL-33, ST2, and ILC Pathways 3
- Psoriasis: Treatment and Pathogenesis 3
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers 4
- Cytokine Signaling Pathways and Interactions 3
- Cancer Research top 10%
- Rheumatology top 5%
-
- Cancer-related gene regulation 6
- Epigenetics and DNA Methylation 5
- Cited by
- ImmunologyOncologyCancer Research
- Journals
- Nature Medicine (2 papers)Nature Communications (1 paper)The Journal of Immunology (1 paper)
- Partner nations
- ChinaAustraliaUnited States
In The Last Decade
Yingxia Zheng
29 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 91
- Immunology 776
- Oncology 452
- Cancer Research 222
- Rheumatology 200
- Molecular Biology 625
Countries citing papers authored by Yingxia Zheng
This map shows the geographic impact of Yingxia Zheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yingxia Zheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yingxia Zheng more than expected).
Fields of papers citing papers by Yingxia Zheng
This network shows the impact of papers produced by Yingxia Zheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yingxia Zheng. The network helps show where Yingxia Zheng may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yingxia Zheng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 2 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 2 | |
| 5 | 2023 | 8 | |
| 6 | 2023 | 6 | |
| 7 | 2022 | 35 | |
| 8 | 2022 | 27 | |
| 9 | 2022 | 20 | |
| 10 | 2021 | 40 | |
| 11 | 2021 | 23 | |
| 12 | 2020 | 282 | |
| 13 | 2019 | 30 | |
| 14 | 2017 | 33 | |
| 15 | 2017 | 23 | |
| 16 | 2017 | 40 | |
| 17 | 2013 | 22 | |
| 18 | 2013 | 418 | |
| 19 | 2012 | 65 | |
| 20 | 2010 | 69 |
About Yingxia Zheng
Yingxia Zheng is a scholar working on Immunology, Cancer Research and Oncology, having authored 31 papers that have together received 1.6k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (9 papers), T-cell and B-cell Immunology (7 papers), Cancer-related gene regulation (6 papers), Epigenetics and DNA Methylation (5 papers), Cancer Immunotherapy and Biomarkers (4 papers), IL-33, ST2, and ILC Pathways (3 papers), Psoriasis: Treatment and Pathogenesis (3 papers) and Cytokine Signaling Pathways and Interactions (3 papers). The work is most often cited by research in Immunology (776 citations), Oncology (452 citations) and Cancer Research (222 citations). Yingxia Zheng has collaborated with scholars based in China, Australia and United States. Frequent co-authors include Lisong Shen, Hong Nie, Dongyi He, Guohua Xie, Jingwu Z. Zhang, Runsheng Li, Yanhui Ma, Lianbo Xiao, Bing Wan and Lei Fang. Their work appears in journals such as Nature Medicine, Nature Communications and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.